tiprankstipranks
Trending News
More News >

Clever Culture Systems Expands APAS® Independence Sales in Pharmaceutical Market

Story Highlights
  • Clever Culture Systems targets the pharmaceutical industry with its APAS® Independence technology.
  • The company has built a sales pipeline with potential sales of $75 million and $15 million in recurring revenue.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Clever Culture Systems Expands APAS® Independence Sales in Pharmaceutical Market

Confident Investing Starts Here:

An update from LBT Innovations Limited ( (AU:CC5) ) is now available.

Clever Culture Systems Ltd has announced significant progress in its sales and marketing efforts for the APAS® Independence technology in the pharmaceutical market. The company has built a substantial sales pipeline with over 40 active customer opportunities, representing potential upfront sales of $75 million and recurring revenue of $15 million annually. The company has received a second purchase order from Bristol Myers Squibb and is in discussions with other multinational pharmaceutical companies following successful evaluations. The expansion of its sales strategy and the introduction of a new analysis module are expected to drive further adoption of its technology, positioning the company for profitability by FY25.

More about LBT Innovations Limited

Clever Culture Systems Ltd is a leader in AI microbiology automation, focusing on the development and marketing of its APAS® Independence technology. The company targets the pharmaceutical industry, aiming to enhance environmental monitoring processes with its innovative solutions.

YTD Price Performance: -35.00%

Average Trading Volume: 687,788

Technical Sentiment Signal: Buy

Current Market Cap: A$22.96M

See more data about CC5 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1